A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
Clinical trial NCT01647789 · TERMINATED
Trial details
- NCT number
- NCT01647789
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-04
- Primary completion
- 2016-02-03
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.